
KUALA LUMPUR (Oct 24): Ta Win Holdings Bhd (KL:TAWIN), a copper wire and rod manufacturer, has proposed a reduction of RM190 million of its issued share capital to clear its substantial accumulated losses.
The announcement, made by the group via a bourse filing on Friday, comes shortly after the lapse of its plan to sell a significant stake in a pharmaceutical business.
The group had accumulated losses of RM179.66 million at the group level and RM53.99 million at the company level, based on its unaudited figures for the financial year ended June 30, 2025 (FY2025), up from RM116.28 million and RM42.19 million, respectively, as at the end of FY2024.
Following the exercise, the group is expected to have retained earnings of RM10.2 million, with retained earnings of RM135.86 million at the company level.
As of Oct 17, Ta Win's issued share capital stood at RM303.64 million, comprising 3.67 billion ordinary shares. On completion of the proposed exercise, expected by the first quarter of 2026, its share capital will be reduced to RM120.61 million.
Two weeks ago, Ta Win announced that its agreement to dispose of a substantial stake in pharmaceutical manufacturer Royce Pharma Manufacturing Sdn Bhd had been mutually terminated. The deal fell through because the buyers — Jelita Serbaneka Sdn Bhd (Royce Pharma’s majority shareholder) and Poly Laboratories Sdn Bhd — failed to secure financing for the purchase.
Under the terminated agreement, Ta Win was to sell a 32.5% stake in Royce Pharma to Jelita Serbaneka and Poly Laboratories for RM20.85 million. Had the deal been completed, Ta Win would have retained a 1.35% stake in Royce Pharma.
Jelita Serbaneka currently owns 54.46% in Royce Pharma, while Ta Win holds a 33.85% stake; Farmasi Express (M) Sdn Bhd has 11%, while Mohamed Azman Mohamed Ariff owns 0.68%.
Ta Win has been loss-making since 2020, which was also when the group first announced its investment in Royce Pharma as part of a strategy "to tap into Covid-19-related business opportunities".
For FY2025, the group’s net loss widened significantly to RM91.97 million from RM15.76 million a year earlier, as revenue dropped 8.8% to RM642.1 million from RM704.04 million.
Shares of Ta Win closed unchanged at 1.5 sen on Friday, with about 305,500 shares traded. This places the group’s market capitalisation at RM41.31 million. Year to date, the counter has fallen by 50%.